lobbying_activities: 3016530

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3016530	969ab138-3352-4216-9a30-0a7785fbeef9	Q2	LANGLEY CONSULTING, LLC	401107117	BOCKORNY GROUP, INC. ON BEHALF OF ELANCO ANIMAL HEALTH	2023	second_quarter	ANI	Issues concerning animal health. HR 1418 - Animal Drug and Animal Generic Drug User Fee Amendments of 2023. S. 1844 - Animal Drug and Animal Generic Drug User Fee Amendments of 2023.	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2023-07-19T14:38:04-04:00